Home/Pipeline/Dry Eye Studies

Dry Eye Studies

Dry Eye Disease

Not Applicable (Service Provider)Active

Key Facts

Indication

Dry Eye Disease

Phase

Not Applicable (Service Provider)

Status

Active

Company

Oculus Research

About Oculus Research

Oculus Research is a private, US-based clinical research organization founded in 2014, operating as a site management organization (SMO) that conducts trials for external sponsors. The company has a strong track record in ophthalmology, having contributed to the development and FDA approval of nine treatments, including TYRVAYA, VEVYE, and MIEBO. Its business model is service-based, generating revenue from sponsors and CROs for patient recruitment and trial execution across a diverse range of therapeutic areas beyond eye care, such as vaccines, diabetes, and mental health.

View full company profile

Therapeutic Areas

Ophthalmology Dry Eye Disease Glaucoma Blepharitis Myopia Neurotrophic Keratopathy Cataract Surgery Retinal Disease Conjunctivitis Vaccines Obesity Diabetes Women's Health Mental Health

Other Dry Eye Disease Drugs

Drug	Company	Phase	Status
Elate Ocular®	Cambium Bio	Phase 3	Active
OT-301	Ocumension Therapeutics	Phase 2	Active
Avarept® Ophthalmic suspension 0.3%	Senju Pharmaceutical	Approved	Active
Dry Eye Care Portfolio	YD Bio	Commercial	Active
MediPrint Lens (Dry Eye)	MediPrint Ophthalmics	Pre-clinical/Research	Active
Tivanisiran	Sylentis	Phase 2/3	Active
A197	Aramis Biosciences	Phase 2	Active
KM102	Theratome Bio	Pre-clinical	Active
iTEAR®100 Commercialization	Olympic Ophthalmics	Commercial	Active
HydraD	EyeD Pharma	Pre-Clinical	Active
ST-100 (Vezocolmitide)	Stuart Therapeutics	Phase 3	Active
BRM421	BRIM Biotechnology	Phase 3	Active (Second Phase 3 trial application submitted 2025)